The role of human papillomavirus infection in prostate carcinoma

References

• Hosseini SY, Danesh AK, Parvin M, Basiri A, Javadzadeh T, Safarinejad MR, . Incidental prostatic adenocarcinoma in patients with PSA less than 4 ng/mL undergoing radical cystoprostatectomy for bladder cancer in Iranian men. Int Braz J Urol 2007;33:167–73.
   PubMedGoogle Scholar
• Parkin DM, Bray FI, Devesa SS. Cancer burden in the year 2000. The global picture. Eur J Cancer 2001;37(Suppl 8):S4–66.
   PubMed Web of Science ®Google Scholar
• Strickler HD, Burk R, Shah K, Viscidi R, Jackson A, Pizza G, . A multifaceted study of human papillomavirus and prostate carcinoma. Cancer 1998;82:1118–25.
   PubMedGoogle Scholar
• Zur Hausen H. Papillomaviruses causing cancer: evasion from host cell control in early events in carcinogenesis. J Natl Cancer Inst 2000;92:690–8.
   PubMed Web of Science ®Google Scholar
• Key T. Risk factors for prostate cancer. Cancer Surv 1995;23:63–77.
   PubMedGoogle Scholar
• IARC Monographs on the evaluation of carcinogenic risks to humans. Human papillomaviruses. 64. Lyon, France: IARC; 1995.
   Google Scholar
• Bosch FX, Manos MM, Muñoz N, Sherman M, Jansen AM, Peto J, . Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International Biological Study on Cervical Cancer (IBSCC) study group. J Natl Cancer Inst (Bethesda) 1995;87:779–80.
   PubMedGoogle Scholar
• Nelson WG, DeMarzo AM, DeWeese TL. The molecular pathogenesis of prostate cancer: focus on the earliest steps. Eur Urol 2001;39(Suppl 4):8–11.
   PubMedGoogle Scholar
• McNicol PJ, Dodd JG. Detection of human papillomavirus DNA in prostate gland tissue by using the polymerase chain reaction amplification assay. J Clin Microbiol 1990;28:409–12.
   PubMed Web of Science ®Google Scholar
• McNicol PJ, Dodd JG. Detection of papillomavirus DNA in human prostatic tissue by Southern blot analysis. Can J Microbiol 1990;36:359–62.
   PubMedGoogle Scholar
• Anwar K, Nakakuki K, Shiraishi T, Naiki H, Yatani R, Inuzuka M. Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas. Cancer Res 1992;52:5991–6.
   PubMed Web of Science ®Google Scholar
• Sarkar FH, Sakr WA, Li YW, Sreepathi P, Crissman JD. Detection of human papillomavirus (HPV) DNA in human prostatic tissues by polymerase chain reaction (PCR). Prostate 1993;22:171–80.
   PubMedGoogle Scholar
• Dodd JG, Paraskevas M, McNicol PJ. Detection of human papillomavirus 16 transcription in human prostate tissue. J Urol 1993;149:400–2.
   PubMedGoogle Scholar
• Al Moustafa AE. Involvement of human papillomavirus infections in prostate cancer progression. Med Hypotheses 2008;71:209–11.
   PubMedGoogle Scholar
• Schiffman MH, Bauer HM, Hoover RN, Glass AG, Cadell DM, Rush BB, . Epidemiological evidence showing that human-papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst 1993;85:958–64.
   PubMed Web of Science ®Google Scholar
• Far AE, Aghakhani A, Hamkar R, Ramezani A, Pishbigar HF, Mirmomen S, . Frequency of human papillomavirus infection in oesophageal squamous cell carcinoma in Iranian patients. Scand J Infect Dis 2007;39:58–62.
   PubMedGoogle Scholar
• Ibrahim GK, Gravitt PE, Dittrich KL, Ibrahim SN, Melhus O, Anderson SM, . Detection of human papillomavirus in the prostate by polymerase chain reaction and in situ hybridization. J Urol 1992;148:1822–6.
   PubMedGoogle Scholar
• Tu H, Jacobs SC, Mergner WJ, Kyprianou N. Rare incidence of human papillomavirus types 16 and 18 in primary and metastatic human prostate cancer. Urology 1994;44: 726–31.
   PubMedGoogle Scholar
• Moyret-Lalle C, Marçais C, Jacquemier J, Moles JP, Daver A, Soret JY, . ras, p53 and HPV status in benign and malignant prostate tumors. Int J Cancer 1995;64:124–9.
   PubMed Web of Science ®Google Scholar
• Suzuki H, Komiya A, Aida S, Ito H, Yatani R, Shimazaki J. Detection of human papillomavirus DNA and p53 mutations in human prostate cancer. Prostate 1996;28:318–24.
   PubMedGoogle Scholar
• Wideroff L, Schottenfeld D, Carey TE, Beals T, Fu G, Sakr W, . Human papillomavirus DNA in malignant and hyperplastic prostate tissue of black and white males. Prostate 1996;28:117–23.
   PubMedGoogle Scholar
• Rosenblatt KA, Carter JJ, Iwasaki LM, Galloway DA, Stanford JL. Serologic evidence of human papillomavirus 16 and 18 infections and risk of prostate cancer. Cancer Epidemiol Biomarkers Prev 2003;12:763–8.
   PubMed Web of Science ®Google Scholar
• Carozzi F, Lombardi FC, Zendron P, Confortini M, Sani C, Bisanzi S, . Association of human papillomavirus with prostate cancer: analysis of a consecutive series of prostate biopsies. Int J Biol Markers 2004;19:257–61.
   PubMedGoogle Scholar
• Korodi Z, Dillner J, Jellum E, Lumme S, Hallmans G, Thoresen S, . Human papillomavirus 16, 18, and 33 infections and risk of prostate cancer: a Nordic nested case–control study. Cancer Epidemiol Biomarkers Prev 2005; 14:2952–5.
   PubMed Web of Science ®Google Scholar
• Leiros GJ, Galliano SR, Sember ME, Kahn T, Schwarz E, Eiguchi K. Detection of human papillomavirus DNA and p53 codon 72 polymorphism in prostate carcinomas of patients from Argentina. BMC Urol 2005;5:15.
   PubMedGoogle Scholar
• Balis V, Sourvinos G, Soulitzis N, Giannikaki E, Sofras F, Spandidos DA. Prevalence of BK virus and human papillomavirus in human prostate cancer. Int J Biol Markers 2007;22:245–51.
   PubMedGoogle Scholar
• McNicol PJ, Dodd JG. High prevalence of human papillomavirus in prostate tissues. J Urol 1991;145:850–3.
   PubMedGoogle Scholar
• Masood S, Rhatigan RM, Powell S, Thompson J, Rodenroth N. Human papillomavirus in prostatic cancer: no evidence found by in situ DNA hybridization. South Med J 1991; 84:235–6.
   PubMedGoogle Scholar
• Effert PJ, Frye RA, Neubauer A, Liu ET, Walther PJ. Human papillomavirus types 16 and 18 are not involved in human prostate carcinogenesis: analysis of archival human prostate cancer specimens by differential polymerase chain reaction. J Urol 1992;147:192–6.
   PubMedGoogle Scholar
• Serfling U, Ciancio G, Zhu WY, Leonardi C, Penneys NS. Human papillomavirus and herpes virus DNA are not detected in benign and malignant prostate tissue using the polymerase chain reaction. J Urol 1992;148:192–4.
   PubMedGoogle Scholar
• Gherdovich S, Barbacci P, Mitrione MP, Farina U, Muraro GB, Anichini M. Detection of the human papillomavirus in hyperplastic and cancerous prostatic tissue with PCR. Minerva Urol Nefrol 1997;49:73–7.
   PubMedGoogle Scholar
• Saad F, Gu K, Jean-Baptiste J, Gauthier J, MesMasson AM. Absence of human papillomavirus sequences in early stage prostate cancer. Can J Urol 1999;6:834–8.
   PubMedGoogle Scholar
• Gazzaz FS, Mosli HA. Lack of detection of human papillomavirus infection by hybridization test in prostatic biopsies. Saudi Med J 2009;30:633–7.
   PubMedGoogle Scholar
• Bergh J, Marklund I, Gustavsson C, Wiklund F, Grönberg H, Allard A, . No link between viral findings in the prostate and subsequent cancer development. Br J Cancer 2007; 96:137–9.
   PubMedGoogle Scholar
• Noda T, Sasagawa T, Dong Y, Fuse H, Namiki M, Inoue M. Detection of human papillomavirus (HPV) DNA in archival specimens of benign prostatic hyperplasia and prostatic cancer using a highly sensitive nested PCR method. Urol Res 1998;26:165–9.
   PubMedGoogle Scholar
• Serth J, Panitz F, Paeslack U, Kuczyk MA, Jonas U. Increased levels of human papillomavirus type 16 DNA in a subset of prostate cancers. Cancer Res 1999;59:823–5.
   PubMedGoogle Scholar
• Hisada M, Rabkin CS, Strickler HD, Wright WE, Christianson RE, van den Berg BJ. Human papillomavirus antibody and risk of prostate cancer. JAMA. 2000;283:340–1.
   PubMedGoogle Scholar
• Adami HO, Kuper H, Andersson SO, Bergström R, Dillner J. Prostate cancer risk and serologic evidence of human papilloma virus infection: a population-based case–control study. Cancer Epidemiol Biomarkers Prev 2003; 12:872–5.
   PubMed Web of Science ®Google Scholar
• Dillner J, Knekt P, Boman J, Lehtinen M, Af Geijersstam V, Sapp M, . Sero-epidemiological association between human-papillomavirus infection and risk of prostate cancer. Int J Cancer 1998;75:564–7.
   PubMed Web of Science ®Google Scholar
• Cuzick J. Human papillomavirus infection of the prostate. Cancer Surv 1995;23:91–5.
   PubMedGoogle Scholar
• Grussendorf-Conen E, Deutz FJ, de Villiers EM. Detection of human papillomavirus-6 in primary carcinoma of the urethra in men. Cancer 1987;60:1832–5.
   PubMedGoogle Scholar
• Scholefield JH, Hickson WG, Smith JH, Rogers K, Sharp F. Anal intraepithelial neoplasia: part of a multifocal disease process. Lancet 1992;340:1271–3.
   PubMedGoogle Scholar
• Kong DB, Zheng XY, Xie LP, Sima N. Is prostate cancer an HPV-associated lesion? Med Hypotheses 2009;72:101.
   PubMedGoogle Scholar
• Kuczyk M, Serth J, Machtens S, Jonas U. Detection of viral HPV 16 DNA in prostate cancer and benign prostatic hyperplasia by quantitative PCR-directed analysis. Prostate Cancer Prostatic Dis 2000;3(S1):S23.
   Google Scholar